Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
2.645
-0.155 (-5.54%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cibus Employees
Cibus had 183 employees as of December 31, 2023. The number of employees increased by 135 or 281.25% compared to the previous year.
Employees
183
Change (1Y)
135
Growth (1Y)
281.25%
Revenue / Employee
$22,694
Profits / Employee
-$2,433,880
Market Cap
78.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
So-Young International | 1,357 |
Karyopharm Therapeutics | 325 |
Generation Bio Co. | 174 |
Adlai Nortye | 127 |
InspireMD | 66 |
PMV Pharmaceuticals | 63 |
Quince Therapeutics | 32 |
Genelux | 23 |
CBUS News
- 5 days ago - Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers - GlobeNewsWire
- 4 weeks ago - Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape - GlobeNewsWire
- 4 weeks ago - Cibus to Participate in the 13th Annual Roth Technology Conference - GlobeNewsWire
- 6 weeks ago - Cibus, Inc. (CBUS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024 - GlobeNewsWire
- 6 weeks ago - Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola - GlobeNewsWire
- 2 months ago - Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call - GlobeNewsWire
- 2 months ago - Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities - GlobeNewsWire